| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Lea Leiv is a Chief Financial Officer at Corvus Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 7 buys and 0 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | CRVS Corvus Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 34,000 | $0.75 | $25,639.00 | +14.9% | -14.8% | +94.9% | |
| Mar 17, 2022 | CRVS Corvus Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 49,038 | $1.57 | $77,045.10 | +36.2% | -38.9% | -54.6% | |
| Jun 7, 2019 | CRVS Corvus Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 25,500 | $3.49 | $88,980.00 | +39.3% | - | - | |
| Dec 21, 2018 | CRVS Corvus Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 24,700 | $4.15 | $102,408.67 | New | - | - |